NO-1886

Product Name: NO-1886
CAS No.: 133208-93-2
Chemical Name: NO-1886
Synonyms: NO-1886;OPF 009;ibrolipim;Ibrolipim NO-1886;NO-1886 Ibrolipim;Ibrolipim, 10 mM in DMSO;Lipoprotein Lipase Activator;4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide;Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate;N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide
CBNumber: CB5497355
Molecular Formula: C19H20BrN2O4P
Formula Weight: 451.25
MOL File: 133208-93-2.mol

More

Less

NO-1886 Property

Melting point:: 160.5-162.1 °C
Boiling point:: 512.5±50.0 °C(Predicted)
Density: 1.44±0.1 g/cm3(Predicted)
storage temp.: Sealed in dry,2-8°C
solubility: DMSO: ≥20mg/mL
form: powder
pka: 11.51±0.70(Predicted)
color: off-white to pale yellow

More

Less

Safety

Hazard Codes: Xi,T
Risk Statements: 36/37/38-25
Safety Statements: 26-36-45
RIDADR: UN 2811 6.1 / PGIII
WGK Germany: 3

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word: Danger
Hazard statements: H301Toxic if swalloed
Precautionary statements: P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: N1540
Product name: NO-1886
Purity: ≥98% (HPLC)
Packaging: 5mg
Price: $165
Updated: 2024/03/01

Sigma-Aldrich

Product number: N1540
Product name: NO-1886
Purity: ≥98% (HPLC)
Packaging: 25mg
Price: $260.8
Updated: 2024/03/01

Cayman Chemical

Product number: 17425
Product name: NO-1886
Purity: ≥98%
Packaging: 5mg
Price: $86
Updated: 2024/03/01

Cayman Chemical

Product number: 17425
Product name: NO-1886
Purity: ≥98%
Packaging: 10mg
Price: $153
Updated: 2024/03/01

Cayman Chemical

Product number: 17425
Product name: NO-1886
Purity: ≥98%
Packaging: 25mg
Price: $343
Updated: 2024/03/01

More

Less

NO-1886 Chemical Properties,Usage,Production

Uses

Antiatherogenic; antiobesity; antidyslipidemia; anticachexia; and antidiabetes/syndrome.

Uses

Lipoprotein Lipase Activator is an inducer of lipoprotein lipase mRNA.

Biological Activity

Lipoprotein lipase activator. Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis. Long-term administration of NO-1886 protects against the development of experimental atherosclerosis in animals.

NO-1886 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

NO-1886 Suppliers

China 44 South Korea 1 Switzerland 1 United States 8 Global 54

SIGMA-RBI

Tel: --
Fax: --
Country: Switzerland
ProdList: 6896
Advantage: 91

133208-93-2, NO-1886Related Search:

3-Bromobenzonitrile DIETHYL 4-METHYLBENZYLPHOSPHONATE N-(2-cyanophenyl)benzamide 2-AMINO-5-BROMOBENZONITRILE DIMETHYL(4-METHYLBENZYL)PHOSPHONATE (4-METHYLBENZYL)PHOSPHONIC ACID 4-(DIETHYLPHOSPHONOMETHYL)BENZALDEHYDE NO-1886

Ibrolipim NO-1886

OPF 009

Lipoprotein Lipase Activator

N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide

NO-1886

Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate

4-diethoxyphosphorylmethyl-N-(4-bromo-2-cyanophenyl)benzamide

ibrolipim

Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate, Ibrolipim, OPF 009

Phosphonic acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, diethyl ester

obesity,fatty,inhibit,NO 1886,Ibrolipim,acid,NO1886,Inhibitor,lipoprotein,lipase,Antihyperlipidemic,UCP3,LDL-C,LXRα,HDL-C

NO-1886 Ibrolipim

Diethyl [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]phosphonate

Ibrolipim, 10 mM in DMSO

133208-93-2

C19H20BrN2O4P